Investor directoryFlerie
Flerie invests in and builds companies with pioneering pharmaceutical and biotech projects or adjacent capabilities.
What they invest in
Sectors
Geographies
global
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Stockholm, Sweden
- Founded
- 2011
More portfolio companies
A3P BiomedicalEgetis Therapeutics (STO: EGTX)Vitara BiomedicalEpiEndo PharmaceuticalsMicrobioticaProkariumSynerkine PharmaGeneos TherapeuticsAmarna TherapeuticsCobra BiologicsProvell PharmaceuticalsBuzzard PharmaceuticalsAtrogiEmpros PharmaKAHR BioAlder TherapeuticsXspray Pharma (STO: XSPRAY)Bonsai BiotherapeuticsBiosergenToleranziaNanologica (STO: NICA)Coriolis PharmaBohus (Other Devices and Supplies)Beactica Therapeutics
and 2 more
Questions founders ask
- How much does Flerie typically invest?
- Flerie states a typical cheque of €1M – €30M.
- Which stages does Flerie invest in?
- Flerie invests at Seed, Series A, Series B and Growth.
- Where is Flerie based?
- Flerie is headquartered in Stockholm, Sweden.
Does Flerie fit your round?
In 30 minutes you'll know which funds matter for your round.
Request accessAre you Flerie? Tell us what to correct and we will update it — or ask us to remove the entry.